Diphen and Exforge drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Diphen (diphenhydramine hydrochloride) and Exforge (amlodipine besylate; valsartan). Common drug interactions include urinary tract infection among females and pain among males.
The phase IV clinical study analyzes what interactions people have when they take Diphen and Exforge. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.
What is Diphen?
Diphen has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 115,432 Diphen users. Check the latest studies of Diphen.
What is Exforge?
Exforge has active ingredients of amlodipine besylate; valsartan. It is often used in high blood pressure. eHealthMe is studying from 13,350 Exforge users. Check the latest studies of Exforge.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
38 people who take Diphen and Exforge together, and have interactions are studied.

What are the common drug interactions of Diphen and Exforge, by gender? *:
female:
- Urinary tract infection
- Diarrhoea
- Sinusitis (inflammation of sinus)
- Chronic kidney disease
- Hypernatraemia (an abnormally high plasma concentration of sodium ions)
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Hypervolaemia (abnormally increased volume of blood)
- Malaise (a feeling of general discomfort or uneasiness)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal failure (kidney dysfunction)
male:
- Pain
- Arthralgia (joint pain)
- Nausea (feeling of having an urge to vomit)
- Pyrexia (fever)
- Type 2 diabetes mellitus
- Urine output decreased
- Vomiting
- Chronic kidney disease
- Febrile neutropenia (fever with reduced white blood cells)
- Injection site extravasation (flow of (blood or lymph) from injection site)
What are the common drug interactions of Diphen and Exforge, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Abscess limb (limb infection)
- Cellulitis of male external genital organ (infection of male genitals soft tissue)
- Chronic kidney disease
- Hyperkalaemia (damage to or disease of the kidney)
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Orchitis (inflammation of the testes)
- Scrotal abscess (pus in scrotum)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Urinary tract infection
30-39:
n/a
40-49:
- Headache (pain in head)
- Pyrexia (fever)
50-59:
- Febrile neutropenia (fever with reduced white blood cells)
- Septic shock (shock due to blood infection)
- Abdominal discomfort
- Anaemia (lack of blood)
- Arthralgia (joint pain)
- Blood creatinine increased
- Epigastric discomfort
- Gastric ulcer (stomach ulcer)
- Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
60+:
- Asthenia (weakness)
- Hyperhidrosis (abnormally increased sweating)
- Nausea (feeling of having an urge to vomit)
- Pyrexia (fever)
- Type 2 diabetes mellitus
- Urine output decreased
- Vomiting
- Upper respiratory tract infection
- Chronic kidney disease
- Injection site extravasation (flow of (blood or lymph) from injection site)
What are the existing conditions these people have? *
- Immunodeficiency Common Variable: 19 people, 50.00%
- High Blood Pressure: 10 people, 26.32%
- Type 2 Diabetes: 4 people, 10.53%
- Pain: 4 people, 10.53%
- Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 10.53%
- Rash Pruritic (redness with itching): 3 people, 7.89%
- Constipation: 2 people, 5.26%
- Diarrhea: 2 people, 5.26%
- Fever: 2 people, 5.26%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 5.26%
* Approximation only. Some reports may have incomplete information.
Do you take Diphen and Exforge?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Diphen and Exforge:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Diphen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Exforge:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Diphen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Exforge and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on diphenhydramine hydrochloride and amlodipine besylate; valsartan (the active ingredients of Diphen and Exforge, respectively), and Diphen and Exforge (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cephalexin cause Pancreatic Cyst? - now
- Could Voltaren cause Radial Nerve Dysfunction? - 14 seconds ago
- Drug interactions of Vinorelbine and Multivitamin - 18 seconds ago
- Acne Aggravated and Nasal Congestion - 22 seconds ago
- Could Ertapenem Sodium cause Radiculopathy? - 26 seconds ago
- Could Bethkis cause Chest Pain? - 34 seconds ago
- Could Ondansetron cause Nephrotic Syndrome? - 35 seconds ago
- Could Betaseron cause Pain? - 36 seconds ago
- Could Effexor Xr cause Dyskinesia? - 39 seconds ago
- Naprosyn vs. Relafen, side effect and effectiveness comparison - 39 seconds ago